This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Accuray's (ARAY) CyberKnife Gets Support From RayStation TPS
by Zacks Equity Research
Accuray (ARAY) introduces RayStation treatment planning support for CyberKnife Radiotherapy System and other radiation therapy devices.
CVS Health (CVS) Introduces Changes in ExtraBucks Program
by Zacks Equity Research
CVS Health's (CVS) retail division to offer instant 2% ExtraBucks rewards on purchases through the ExtraCare Rewards loyalty program.
The Zacks Analyst Blog Highlights: NVIDIA, Target, Lam Research, Alphabet and Intuitive Surgical
by Zacks Equity Research
The Zacks Analyst Blog Highlights: NVIDIA, Target, Lam Research, Alphabet and Intuitive Surgical
If You Invested $1000 in Intuitive Surgical, Inc. a Decade Ago, This is How Much It'd Be Worth Now
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Here's Why Intuitive Surgical, Inc. (ISRG) is a Great Momentum Stock to Buy
by Zacks Equity Research
Does Intuitive Surgical, Inc. (ISRG) have what it takes to be a top stock pick for momentum investors? Let's find out.
Here's Why You Should Invest in Intuitive Surgical (ISRG) Now
by Zacks Equity Research
Intuitive Surgical (ISRG) continues to gain traction from improving adoption of da Vince Surgical System.
Veeva (VEEV) Customer Intelligence Platform Reaches New Areas
by Zacks Equity Research
Veeva Link's expansion across 11 new therapeutic areas to drive engagement for Veeva's (VEEV) partner companies with key experts.
U.S. Household Net Worth Hits Record High in Q1: 5 Picks
by Nalak Das
We have narrowed down our search to five U.S. corporate behemoths that have popped more than 15% in the past three months. These are NVDA, GOOGL, TGT, LRCX and ISRG.
Tandem (TNDM) Presents Data Backing Control-IQ Technology
by Zacks Equity Research
Data presented at the ATTD conference demonstrates Tandem Diabetes Care's (TNDM) Control-IQ technology's ability to make a positive and sustained impact on diabetes care.
The Zacks Rank Explained: How to Find Strong Buy Medical Stocks
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Rank.
Why Is Intuitive Surgical, Inc. (ISRG) Down 8.4% Since Last Earnings Report?
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Top Analyst Reports for Amazon, Tesla & NextEra
by Sheraz Mian
Today's Research Daily features new research reports on 12 major stocks, including Amazon.com (AMZN), Tesla (TSLA), and NextEra Energy (NEE).
Here's Why You Should Retain Intuitive Surgical (ISRG) Now
by Zacks Equity Research
Intuitive Surgical (ISRG) continues to gain traction from improving adoption of da Vince Surgical System. However, rise in production costs is a woe.
The Zacks Analyst Blog Highlights: Deere, Cognex, Rockwell Automation, ABB and Intuitive Surgical
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Deere, Cognex, Rockwell Automation, ABB and Intuitive Surgical
5 Stocks to Watch as Automation Drives Demand for Robotics
by Kaustav Ghosh
Increased efficiency and precision has been driving demand for robotics across industries, making it wise to look at names like Deere & Co. (DE), Cognex (CGNX), ABB (ABB) and Intuitive Surgical (ISRG)
The Zacks Analyst Blog Highlights: Johnson & Johnson, Stryker, Boston Scientific Corp, Intuitive Surgical and Asensus Surgical
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Johnson & Johnson, Stryker, Boston Scientific Corp, Intuitive Surgical and Asensus Surgical
Innovation Drives Robotic-Assisted Surgery: 5 Stocks to Watch
by Sreoshi Bera
Rapid innovation is boosting the robotic surgery space, putting the spotlight on Johnson & Johnson (JNJ), Stryker (SYK), Boston Scientific (BSX), Intuitive Surgical (ISRG) and Asensus Surgical (ASXC).
Here's How Much You'd Have If You Invested $1000 in Intuitive Surgical, Inc. a Decade Ago
by Zacks Equity Research
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
Intuitive Surgical, Inc. (ISRG) Surges 9.9%: Is This an Indication of Further Gains?
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Intuitive Surgical (ISRG) Q1 Earnings & Revenues Top Estimates
by Zacks Equity Research
Intuitive Surgical's (ISRG) first-quarter results reflect strong segmental performance.
Intuitive Surgical, Inc. (ISRG) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) delivered earnings and revenue surprises of 34.87% and 16.21%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Why You Should Hold AngioDynamics (ANGO) in Your Portfolio
by Zacks Equity Research
Investor optimism is high on AngioDynamics (ANGO) stock, courtesy of its solid prospects.
Cardinal Health (CAH), HHS Partner to Offer Pandemic Support
by Zacks Equity Research
The contract should help Cardinal Health (CAH) provide critical pandemic support in partnership with the U.S. government.
Thermo Fisher (TMO) to Expand in Pharma Service With PPD Buyout
by Zacks Equity Research
Thermo Fisher's (TMO) $17.4-billion acquisition deal will offer the company meaningful cost and revenue synergies.
STERIS (STE) Hits a New 52-Week High: What's Driving It?
by Zacks Equity Research
Investors are optimistic about STERIS (STE) backed by elevated consumer demand and strong segmental growth in third-quarter fiscal 2021.